1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Bowel Obstruction: new trials by email Literature Review of Bowel Obstruction trials Research Report on Bowel Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian Cancer Cediranib - Bowel Obstruction, Ovarian Cancer | Phase 2 | Completed | Prof Gordon Jayson | 30 | 2018-05-14 | 2026-06-15 |
| Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction Cisplatin, Paclitaxel - Ovarian Cancer, Peritoneal Cancer | Phase 1 / Phase 2 | Terminated | University Health Network, Toronto | 1 | 2010-02-01 | 2019-02-15 |
Fallopian Tube Neoplasms (2) · Intestinal Obstruction (2) · Ovarian Neoplasms (2)
Adnexal Diseases (2) · Digestive System Diseases (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Fallopian Tube Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Gastrointestinal Diseases (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Gonadal Disorders (2) · Intestinal Diseases (2) · Neoplasms (2) · Neoplasms by Site (2)
Cisplatin (1) · Paclitaxel (1) · cediranib (1)
Prof Gordon Jayson (1) · University Health Network, Toronto (1)
Canada (1) · United Kingdom (1)
Amit Oza (1) · Andrew Clamp (1) · Nicole Chau (1)
2016 (1)